NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products
In June 2025 NRx filed an Abbreviated New Drug Application with the FDA for a preservative-free preparation of ketamine, demonstrating support for 3 year room temperature stability and sterility. NRx has similarly filed a patent on its preservative-free process, in light of prior art that suggested BZT was required for long term stability and sterility. The Company has instituted US-based high volume manufacture, while it awaits generic approval. The Company is additionally seeking a labeled indication for the use of ketamine to treat suicidal depression through the recently-announced FDA Commissioner's National Priority Voucher Program.
'At its introduction in the 1970s, ketamine was developed as an anesthetic and was never intended to be administered repeatedly to patients,' said Dr. Jonathan Javitt, CEO of NRx Pharmaceuticals. 'Ketamine is now widely used on a repeated basis as the only currently marketed drug that has shown benefit in treating suicidal depression and PTSD, although this is currently not a labeled indication. Hence, patients who receive intravenous ketamine on a repeated basis are exposed to a known toxic preservative that cannot be used today in hand cleaner, antiseptics, and other topical products. The European Medicines Agency has warned against its use.2 We believe that our Citizen Petition aligns with priorities articulated by current leadership of the US Department of Health and Human Services to remove potentially toxic additives and preservatives from the US Food and Drug supply and to re-shore the US Drug Supply.'
About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia.
NRx has recently filed an Abbreviated New Drug Application (ANDA) for preservative-free ketamine and initiated a New Drug Application filing for NRX-100 (IV ketamine) under the Commissioner's National Priority Voucher Program for the treatment of suicidal depression. The filing is based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'believe,' 'intend,' 'look forward,' and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, including uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy, and, among other things, liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, the Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
For further information:
1 U.S. Food and Drug Administration. Final Rule: Safety and Effectiveness of Consumer Antiseptic Wash Products. 81 FR 61106. September 6, 2016. https://www.federalregister.gov/d/2016-21337
2 European Medicines Agency (EMA). (2020). Questions and answers on benzalkonium chloride used as an excipient in medicinal products for human use [PDF]. EMA. https://www.ema.europa.eu/en/documents/scientific-guideline/questions-and-answers-benzalkonium-chloride-used-excipient-medicinal-products-human-use_en.pdf
View original content to download multimedia: https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-announces-filing-of-a-citizen-petition-with-the-us-food-and-drug-administration-seeking-removal-of-benzethonium-chloride-from-ketamine-products-302520439.html
SOURCE NRx Pharmaceuticals, Inc.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Geek Wire
a few seconds ago
- Geek Wire
Blue Origin and five other companies study how orbital transfer vehicles can aid NASA
An artist's conception shows the Blue Ring space platform in orbit. (Blue Origin Illustration) Jeff Bezos' Blue Origin space venture is among six companies that will be producing studies for NASA looking at low-cost ways to use orbital transfer vehicles to deliver spacecraft to hard-to-reach orbits for the space agency. The awards will support nine studies in all, with a maximum total value of about $1.4 million, NASA said today. 'With the increasing maturity of commercial space delivery capabilities, we're asking companies to demonstrate how they can meet NASA's need for multi-spacecraft and multi-orbit delivery to difficult-to-reach orbits beyond current launch service offerings,' Joe Dant, orbital transfer vehicle strategic initiative owner for the Launch Services Program at NASA's Kennedy Space Center, said in a news release. 'This will increase unique science capability and lower the agency's overall mission costs.' Blue Origin will conduct two studies — one that focuses on potential NASA applications for its Blue Ring multi-mission space mobility platform, and another that focuses on how the upper stage of its New Glenn rocket could be used. The first New Glenn launch sent a test payload for the Blue Ring program into orbit in January. The second New Glenn launch is due to put twin orbiters on a path to Mars for NASA's ESCAPADE mission later this year. Blue Origin's first full-scale Blue Ring spacecraft is currently scheduled for launch in 2026, with Scout Space's Owl space domain sensors among the payloads. The other companies involved in NASA's studies are: Texas-based Arrow Science and Technology , which will partner with Quantum Space to study applications for Quantum's Ranger spacecraft. , which will partner with Quantum Space to study applications for Quantum's Ranger spacecraft. Texas-based Firefly Aerospace , which will focus on potential uses for its line of Elytra orbital vehicles. Firefly acquired Seattle-based Spaceflight Inc. in 2023, and its Elytra vehicles draw upon the heritage of Spaceflight's Sherpa vehicles. , which will focus on potential uses for its line of Elytra orbital vehicles. Firefly acquired Seattle-based Spaceflight Inc. in 2023, and its Elytra vehicles draw upon the heritage of Spaceflight's Sherpa vehicles. California-based Impulse Space , which will produce two studies focusing on its highly maneuverable Mira spacecraft and its high-energy Helios kick stage. , which will produce two studies focusing on its highly maneuverable Mira spacecraft and its high-energy Helios kick stage. California-based Rocket Lab USA , with one study focusing on the upper stage of its Neutron rocket, and the other focusing on a long-life orbital transfer vehicle based on its Explorer spacecraft. , with one study focusing on the upper stage of its Neutron rocket, and the other focusing on a long-life orbital transfer vehicle based on its Explorer spacecraft. Colorado-based United Launch Alliance, which will assess the cislunar mission capabilities of an extended-duration Centaur V upper stage. The studies are due to be complete by mid-September, and NASA will incorporate the findings into its plans for future space missions.


CBS News
2 minutes ago
- CBS News
Novato city workers go on strike, say better wages will help retain workforce
Municipal workers in Novato didn't show up for work Tuesday morning after contract negotiations with the city stalled. The striking union members said they have the support of the public in this fight, and they point to information on the city's own website that says it has the money to pay them more. The SEIU contract expired on June 30, and now, they're taking their case directly to the public, a public that recently taxed itself to support the very tasks that the union workers perform every day. "That kind of support is what we've been looking for for a long time," said worker Paul Perryman. It's not every day that residents applaud city workers for not being on the job. But in Novato, signs hang in the windows of many downtown businesses expressing support for the workers. In fact, voters approved Measure M in November to raise the sales tax to support everyday services. The campaign promised the annual $10 million would be spent on "potholes, parks and police." "When they use the campaign as 'potholes, parks and police,' you know, the potholes don't get filled without our maintenance staff. The parks and medians and streets aren't cleaned without our maintenance staff," said Brett Walker, a city senior planner and member of SEIU's negotiating team. Union workers in those units were on strike Tuesday, demanding higher wages that they say will help the city retain its workforce. The union said one out of five employees has been on the job for less than a year. "I've had a few co-workers that have actually left to other jurisdictions, when they live here in the city! They've gone to neighboring jurisdictions because they pay higher," said city planner David Ayala, who has been on the job for about two and a half years. "I see the kind of rotating door all the time. And it's just, Novato, unfortunately, has kind of gained that reputation." On Novato's website, it describes Measure M, saying, "The City will begin receiving funds in July 2025 to directly support community identified priorities such as public safety and emergency response, roadway repairs, and parks and facilities maintenance." And in a statement, they said the sales tax money was being used for that purpose, offering 11% raises over three years for all SEIU employees. But Perryman, who works on street maintenance and is one of those guys filling potholes, said more needs to be spent to bolster the exhausted workforce. "We're burnt. We're doing the best we can," he said. "The biggest problem is our staffing is less than it was in 2006. The streets crew specifically was over 14. The street crew right now is seven. And four of us are the ones doing the potholes." No city is flush with cash these days, but the union said the voters were clear about how they wanted the Measure M money spent. And, they said, in this case it was to support the workers. "This is the strongest we've had support from the community in a long time in Novato that I know of. That I can remember," Perryman said. "That feels good, really good. And it helps. Because I still enjoy my job. I like to drive over that pothole that I fixed. There's a satisfaction to that, you know, 'They can't complain about that one anymore!'" The city said it was only notified about the strike on the previous evening, and it had not been told when the workers will be back. The union said they don't know how long it will last, and that decision will be made on a day-by-day basis.


Fox News
2 minutes ago
- Fox News
Fox Corporation's new 'FOX One' streaming service to launch August 21
FOX One, Fox Corporation's new streaming service that will integrate all of its popular television brands on a single platform, will officially launch August 21. "FOX One is a truly innovative digital offering launching across the U.S. on August 21 for $19.99 per month," FOX Corporation Executive Chair and CEO Lachlan Murdoch announced on Tuesday's earnings call. "While FOX One will be marketed to the cordless market, current Pay TV subscribers will also have access to FOX One on an authenticated basis." FOX One will provide live-streaming and on-demand access to all Fox brands, including Fox News, FOX Business, FOX Weather, FOX Sports, FS1 (Fox Sports 1), FS2, BTN (Big Ten Network), FOX Deportes, FOX Local Stations and the FOX Network. Users have the option of paying $19.99 monthly or $199.99 annually. They will also be able to bundle FOX One and FOX Nation for $24.99 per month or the equivalent of $19.99 per month when purchasing the annual plan at its launch. Murdoch teased the "cutting edge" technology that's built into the customizable interface. "The FOX One user interface is incredibly innovative," Murdoch said. "It can be very highly personalized and relies on some very clever technology to offer something that's truly unique in the marketplace." In addition to many other exciting features, FOX One will feature advanced, AI-powered personalization technologies that seamlessly integrate live and video on-demand content in a cohesive experience. Users will have access to on-demand content from FOX Entertainment, including movies, TV shows, comedies, reality TV, FAST Channels like LiveNOW and TMZ, as well as FOX podcasts. FOX One will be available on all major platforms and devices, including on iOS, Android, Roku, Fire TV, Apple TV, LG, Samsung, Xbox and web browsers. The latest updates and information about the upcoming service are available at